Álvaro de la Cruz Potenciano is an R&D Scientist and postdoctoral researcher with a PhD in Medicinal Chemistry. His expertise is focused on antiviral drug discovery, particularly targeting infectious respiratory viruses such as influenza and coronaviruses, and includes exposure to rare diseases.